Safety and Efficacy of Sufentanil Administration by Paramedics in Acute Trauma

NCT ID: NCT06514469

Last Updated: 2024-07-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-01

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The safety and efficacy of competence of paramedics to administer sufentanil intravenously in adult acute trauma patients without presence or without phone-call consult with an emergency medical doctor will be assessed in this observational study.

Condition or disease: pain in trauma or injury. Intervention/treatment: sufentanil administered by paramedics after the phone call consultation of medical doctor versus sufentanil administered by paramedics based on their competency, without consultation of medical doctor.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The administration and indication of an opioid analgesics is carried by a medical doctor in most European emergency services. However, trips to majority of less serious traumas are realized by ambulances with paramedic crews without a medical doctor present on site.

This study will assess the new competence of paramedics to administer opioid analgesics without presence or phone-call consult with an emergency medical doctor.

This study will address the safety and efficacy of sufentanil administered by the paramedics in the field to patients with acute trauma without any consultation with medical doctors.

This study will complement the recently published data of the previous study, which, however, took place during the outbreak of COVID-19 and this lockdown situation could have distorted the frequency and nature of the observed cases.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Injury Traumatic Pain, Acute

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Consultation

Patient who were administered sufentanil in acute trauma by paramedics after phone call consultation with medical doctor.

Sufentanil intravenous administration followed consultation of remote physician

Intervention Type DRUG

Intravenous administration of sufentanil to patients with acute injury by paramedics only after phone-call consultation of medical doctor.

Competency

Patient who were administered sufentanil in acute trauma by paramedics based on their competencies.

Sufentanil intravenous administration based on paramedic competency

Intervention Type DRUG

Intravenous administration of sufentanil to patients with acute injury by paramedics based on their competencies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sufentanil intravenous administration followed consultation of remote physician

Intravenous administration of sufentanil to patients with acute injury by paramedics only after phone-call consultation of medical doctor.

Intervention Type DRUG

Sufentanil intravenous administration based on paramedic competency

Intravenous administration of sufentanil to patients with acute injury by paramedics based on their competencies

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Consultation Competency

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* acute trauma with severe pain (VAS/NRS \> 4)
* age \> 18 years
* conscious patient (GCS = 15; alert in AVPU)
* haemodynamically stable patient (\> 100mmHg of systolic blood pressure, \> 60/min of heart rate)

Exclusion Criteria

* EMS doctor on site
* paediatric patient (less than 18 years)
* predominantly chronic but not acute pain
* incomplete documentation
* other than traumatic reasons for opioid administration (eg. acute coronary syndrome)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zdravotnicka Zachranna Sluzba Karlovarskeho Kraje, P.O.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Roman Sýkora, MD, Ph.D.

Researcher, physician

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jiří Smetana, MD

Role: STUDY_DIRECTOR

Zdravotnická záchranná služba Karlovarského kraje, příspěvková organizace

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zdravotnická záchranná služba Karlovarského kraje, příspěvková organizace

Karlovy Vary, Karlovy Vary Region, Czechia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Czechia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Roman Sýkora, PhD

Role: CONTACT

+420602524203

David Peřan, PhD

Role: CONTACT

+420728315535

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Roman Sýkora, PhD

Role: primary

+420602524203

David Peřan, PhD

Role: backup

+420728315535

References

Explore related publications, articles, or registry entries linked to this study.

Renza M, Sykora R, Peran D, Hricova K, Brizgalova N, Bakurova P, Kukacka M. Pilot implementation of the competence of Czech paramedics to administer sufentanil for the treatment of pain in acute trauma without consulting a physician: observational study. BMC Emerg Med. 2022 Apr 9;22(1):63. doi: 10.1186/s12873-022-00622-8.

Reference Type RESULT
PMID: 35397498 (View on PubMed)

Scharonow M, Alberding T, Oltmanns W, Weilbach C. Project for the introduction of prehospital analgesia with fentanyl and morphine administered by specially trained paramedics in a rural service area in Germany. J Pain Res. 2017 Nov 6;10:2595-2599. doi: 10.2147/JPR.S151077. eCollection 2017.

Reference Type RESULT
PMID: 29158691 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Sufentanil02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.